Chiu J F, Hnilica L S, Chytil F, Orrahood J T, Rogers L W
J Natl Cancer Inst. 1977 Jul;59(1):151-4. doi: 10.1093/jnci/59.1.151.
Tissue-specific antisera against human lung and breast carcinoma dehistonized chromatins were obtained. The specificity of these antisera was determined by complement fixation. In the presence of antiserum against human lung carcinoma, only chromatins from lung carcinoma fixed complement significantly, whereas chromatins isolated from human breast carcinoma, HeLa cells, normal lung tissue, breast tissue, or term placenta were negative (i.e., inactive). In a similar assay with the use of antiserum against dehistonized breast carcinoma chromatins, only breast carcinoma chromatins fixed complement. Immunohistochemical localization of the antigens by the horseradish peroxidase bridge method demonstrated their presence in the nuclei.
获得了针对人肺癌和乳腺癌去组蛋白染色质的组织特异性抗血清。这些抗血清的特异性通过补体结合试验来确定。在存在抗人肺癌抗血清的情况下,只有肺癌染色质能显著结合补体,而从人乳腺癌、HeLa细胞、正常肺组织、乳腺组织或足月胎盘分离的染色质均为阴性(即无活性)。在使用抗去组蛋白乳腺癌染色质抗血清的类似试验中,只有乳腺癌染色质能结合补体。通过辣根过氧化物酶桥法对抗原进行免疫组织化学定位显示它们存在于细胞核中。